Filing Flows › Agilent Technologies (A) › Q2 FY26 › vs Q2 FY25
Agilent Technologies (A) Q2 FY26 vs Q2 FY25 (year over year)
Agilent Technologies's revenue rose $167M (+10%) from $1.7B in Q2 FY25 to $1.8B in Q2 FY26. The biggest changes: Life Sciences and Diagnostics Markets +$78.0M (+12%); Agilent CrossLab +$46.0M (+6%); Applied Markets +$43.0M (+14%). Operating margin 21.7% against 18.0% (+3.8 pts).
Agilent Technologies, Q2 FY26: revenue $1.8B (+10% year over year), operating margin 21.7%, net earnings $339M, operating cash flow $277M. The chart draws each line against Q2 FY25, the increases inside each band.
Margins
| Q2 FY26 | Q2 FY25 | Change | |
|---|---|---|---|
| Operating margin | 21.7% | 18.0% | +3.8 pts |
| Net margin | 18.5% | 12.9% | +5.6 pts |
| Free cash flow margin | 11.0% | 6.4% | +4.5 pts |
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Agilent CrossLab | $759M | $713M | $46.0M | +6% |
| Life Sciences and Diagnostics Markets | $732M | $654M | $78.0M | +12% |
| Applied Markets | $344M | $301M | $43.0M | +14% |
| Revenue | $1.8B | $1.7B | $167M | +10% |
| Other income, net | $9.0M | −$40.0M | $49.0M | — |
| Operating profit | $399M | $300M | $99.0M | +33% |
| Costs & expenses | $1.4B | $1.4B | $68.0M | +5% |
| Pre-tax earnings | $408M | $260M | $148M | +57% |
| Cost of revenue | $845M | $802M | $43.0M | +5% |
| Research & development | $126M | $112M | $14.0M | +12% |
| SG&A | $465M | $454M | $11.0M | +2% |
| Net earnings | $339M | $215M | $124M | +58% |
| Income tax | $69.0M | $45.0M | $24.0M | +53% |
| Depreciation & amortization | $67.0M | $73.0M | −$6.0M | -8% |
| Share-based compensation | $32.0M | $30.0M | $2.0M | +7% |
| Working capital & other | $161M | $97.0M | $64.0M | +66% |
| Operating cash flow | $277M | $221M | $56.0M | +25% |
| Free cash flow (OCF − capex) | $201M | $107M | $94.0M | +88% |
| Capital expenditures | $76.0M | $114M | −$38.0M | -33% |
Questions
How much did Agilent Technologies's revenue grow year over year in Q2 FY26?
Agilent Technologies's revenue rose $167M (+10%) from $1.7B in Q2 FY25 to $1.8B in Q2 FY26.
What drove Agilent Technologies's revenue change in Q2 FY26?
Life Sciences and Diagnostics Markets +$78.0M (+12%); Agilent CrossLab +$46.0M (+6%); Applied Markets +$43.0M (+14%).